The Patent Finder

Exithera Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Exithera Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 5 of 5 · Back to Exithera Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,994,521Therapeutic Compounds and Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,152,014Therapeutic compounds and compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,691,962Therapeutic compounds and compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,501,404Substituted azetidinones
Formerly held
Term ended
Term ended May 25, 2026 · From the USPTO record
Term endedTerm ended May 25, 2026From the USPTO record
US 7,217,794Compounds and methods for treatment of thrombosis
Lapsed on the fee record
Ended May 15, 2019 · From the USPTO record
Lapsed on the fee recordEnded May 15, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited